Search

Sean E. Aeder

Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1939
Issued Applications
907
Pending Applications
201
Abandoned Applications
855

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10932031 [patent_doc_number] => 20140335050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/122531 [patent_app_country] => US [patent_app_date] => 2012-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 72940 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122531 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/122531
METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER May 24, 2012 Abandoned
Array ( [id] => 8866015 [patent_doc_number] => 20130149718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'METHODS OF DETERMINING CELLULAR CHEMOSENSITIVITY' [patent_app_type] => utility [patent_app_number] => 13/478831 [patent_app_country] => US [patent_app_date] => 2012-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 16763 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13478831 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/478831
Methods of determining cellular chemosensitivity May 22, 2012 Issued
Array ( [id] => 8696932 [patent_doc_number] => 20130058940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'Novel Gene And Protein Associated With Angiogenesis And Endothelial Cell Specific Apoptosis' [patent_app_type] => utility [patent_app_number] => 13/476936 [patent_app_country] => US [patent_app_date] => 2012-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 26466 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13476936 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/476936
Novel Gene And Protein Associated With Angiogenesis And Endothelial Cell Specific Apoptosis May 20, 2012 Abandoned
Array ( [id] => 8495880 [patent_doc_number] => 20120295288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'SEROLOGICAL MARKER FOR DETECTING PANCREATIC CANCER AND A METHOD FOR USING THE SEROLOGICAL MARKER' [patent_app_type] => utility [patent_app_number] => 13/475658 [patent_app_country] => US [patent_app_date] => 2012-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3579 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475658 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/475658
SEROLOGICAL MARKER FOR DETECTING PANCREATIC CANCER AND A METHOD FOR USING THE SEROLOGICAL MARKER May 17, 2012 Abandoned
Array ( [id] => 9823711 [patent_doc_number] => 08933196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Peptide chromatographic purification assisted by combining of solubility parameter and solution conformation energy calculations' [patent_app_type] => utility [patent_app_number] => 13/472152 [patent_app_country] => US [patent_app_date] => 2012-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5379 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13472152 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/472152
Peptide chromatographic purification assisted by combining of solubility parameter and solution conformation energy calculations May 14, 2012 Issued
Array ( [id] => 9060116 [patent_doc_number] => 08546551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Method to detect prostate cancer in a sample' [patent_app_type] => utility [patent_app_number] => 13/470451 [patent_app_country] => US [patent_app_date] => 2012-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16753 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470451 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/470451
Method to detect prostate cancer in a sample May 13, 2012 Issued
Array ( [id] => 9698612 [patent_doc_number] => 20140248297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'PREDICTORS OF RESPONSE TO IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 14/117322 [patent_app_country] => US [patent_app_date] => 2012-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5631 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117322 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/117322
PREDICTORS OF RESPONSE TO IMMUNOTHERAPY May 10, 2012 Abandoned
Array ( [id] => 9463281 [patent_doc_number] => 20140127708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'PREDICTIVE BIOMARKERS FOR PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 14/115430 [patent_app_country] => US [patent_app_date] => 2012-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 48217 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14115430 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/115430
PREDICTIVE BIOMARKERS FOR PROSTATE CANCER May 7, 2012 Abandoned
Array ( [id] => 8370598 [patent_doc_number] => 20120219982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'METHODS FOR SELECTING ACTIVE AGENTS FOR CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/461079 [patent_app_country] => US [patent_app_date] => 2012-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8923 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13461079 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/461079
METHODS FOR SELECTING ACTIVE AGENTS FOR CANCER TREATMENT Apr 30, 2012 Abandoned
Array ( [id] => 9330107 [patent_doc_number] => 20140056889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'COMPOSITIONS AND METHOD FOR TREATING AUTOIMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 14/113575 [patent_app_country] => US [patent_app_date] => 2012-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 71302 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113575 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/113575
COMPOSITIONS AND METHOD FOR TREATING AUTOIMMUNE DISEASES Apr 25, 2012 Abandoned
Array ( [id] => 8431145 [patent_doc_number] => 20120253020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways' [patent_app_type] => utility [patent_app_number] => 13/454642 [patent_app_country] => US [patent_app_date] => 2012-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 22887 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13454642 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/454642
Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways Apr 23, 2012 Abandoned
Array ( [id] => 8932406 [patent_doc_number] => 08492104 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Methods and kits to detect and monitor ovarian cancer and preeclampsia' [patent_app_type] => utility [patent_app_number] => 13/454276 [patent_app_country] => US [patent_app_date] => 2012-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13869 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13454276 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/454276
Methods and kits to detect and monitor ovarian cancer and preeclampsia Apr 23, 2012 Issued
Array ( [id] => 8495877 [patent_doc_number] => 20120295286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'Methods for the Diagnosis, Prognosis and Monitoring of Cancer Therapy Using BP1' [patent_app_type] => utility [patent_app_number] => 13/453432 [patent_app_country] => US [patent_app_date] => 2012-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6539 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13453432 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/453432
Methods for the Diagnosis, Prognosis and Monitoring of Cancer Therapy Using BP1 Apr 22, 2012 Abandoned
Array ( [id] => 8779623 [patent_doc_number] => 20130101599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'BCMA-BASED STRATIFICATION AND THERAPY FOR MULTIPLE MYELOMA PATIENTS' [patent_app_type] => utility [patent_app_number] => 13/450716 [patent_app_country] => US [patent_app_date] => 2012-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13565 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13450716 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/450716
BCMA-BASED STRATIFICATION AND THERAPY FOR MULTIPLE MYELOMA PATIENTS Apr 18, 2012 Abandoned
Array ( [id] => 8370117 [patent_doc_number] => 20120219502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'METHODS AND COMPOSITIONS FOR TARGETING GC1QR/P32' [patent_app_type] => utility [patent_app_number] => 13/448820 [patent_app_country] => US [patent_app_date] => 2012-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 38240 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448820 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/448820
METHODS AND COMPOSITIONS FOR TARGETING GC1QR/P32 Apr 16, 2012 Abandoned
Array ( [id] => 9016508 [patent_doc_number] => 20130231472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'USE OF MOLECULAR MARKERS FOR THE PRECLINICAL PROFILING OF INHIBITORS OF ENZYMES HAVING HISTONE DEACETYLASE ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/447797 [patent_app_country] => US [patent_app_date] => 2012-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11732 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13447797 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/447797
USE OF MOLECULAR MARKERS FOR THE PRECLINICAL PROFILING OF INHIBITORS OF ENZYMES HAVING HISTONE DEACETYLASE ACTIVITY Apr 15, 2012 Abandoned
Array ( [id] => 8335110 [patent_doc_number] => 20120201817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'METHODS OF INHIBITING RECEPTOR TYROSINE KINASES WITH AN EXTRACELLULAR ANTAGONIST AND AN INTRACELLULAR ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 13/445239 [patent_app_country] => US [patent_app_date] => 2012-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8043 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13445239 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/445239
METHODS OF INHIBITING RECEPTOR TYROSINE KINASES WITH AN EXTRACELLULAR ANTAGONIST AND AN INTRACELLULAR ANTAGONIST Apr 11, 2012 Abandoned
Array ( [id] => 8721212 [patent_doc_number] => 20130072429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'ASSAYS AND METHODS USING BIOMARKERS' [patent_app_type] => utility [patent_app_number] => 13/444500 [patent_app_country] => US [patent_app_date] => 2012-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 29628 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13444500 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/444500
ASSAYS AND METHODS USING BIOMARKERS Apr 10, 2012 Abandoned
Array ( [id] => 8394130 [patent_doc_number] => 20120231966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'LUNG CANCER DIAGNOSTIC ASSAY' [patent_app_type] => utility [patent_app_number] => 13/430474 [patent_app_country] => US [patent_app_date] => 2012-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15755 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13430474 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/430474
LUNG CANCER DIAGNOSTIC ASSAY Mar 25, 2012 Abandoned
Array ( [id] => 10008111 [patent_doc_number] => 09051619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-09 [patent_title] => 'Methods and compositions for prostate cancer metastasis' [patent_app_type] => utility [patent_app_number] => 13/428750 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 16141 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13428750 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/428750
Methods and compositions for prostate cancer metastasis Mar 22, 2012 Issued
Menu